1.
BMJ Case Rep
; 14(7)2021 Jul 29.
Article
in English
| MEDLINE
| ID: mdl-34326107
ABSTRACT
Omalizumab is an anti-IgE monoclonal antibody used in severe allergic asthma. Herein, we describe a case of eosinophilic granulomatosis with polyangiitis, which manifested 3 months after initiation of omalizumab therapy, while maintenance corticosteroid therapy dose was unchanged.